Latest News by Industry
DUBLIN--(BUSINESS WIRE)--Nov 21, 2022--
The "Pharmacovigilance & Drug Safety Software Market Intelligence Report - Global Forecast to 2027" report has been added to ResearchAndMarkets.com's offering.
The Global Pharmacovigilance & Drug Safety Software Market is projected to reach USD 940.58 million by 2027 from USD 426.74 million in 2021, at a CAGR of 14.07% during the forecast period.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available.
In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
The report on pharmacovigilance & drug safety software identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan.
This research report categorizes the pharmacovigilance & drug safety software to forecast the revenues and analyze the trends in each of the following sub-markets:
Product:
Clinical Trial:
Distribution:
End User:
Region:
Company Usability Profiles:
For more information about this report visit https://www.researchandmarkets.com/r/hiwrly
View source version on businesswire.com:https://www.businesswire.com/news/home/20221121005363/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: SOFTWARE TECHNOLOGY PHARMACEUTICAL HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/21/2022 05:07 AM/DISC: 11/21/2022 05:07 AM
http://www.businesswire.com/news/home/20221121005363/en